CT-GFP Fusion TOPO™ Expression Kit
Product Image
Invitrogen™

CT-GFP Fusion TOPO™ Expression Kit

当社のCT GFP-fusion TOPO™ Expression Kitは、緑色蛍光タンパク質(GFP)を、Taqポリメラーゼ増幅遺伝子産物のC末端に融合する、高効率で5分間のクローニング用のpcDNA™3.1⁄CT-GFP-TOPO™ベクターを提供します詳細を見る
製品番号(カタログ番号)数量
K48200120 reactions
製品番号(カタログ番号) K482001
価格(JPY)
163,400
Each
お問い合わせください ›
数量:
20 reactions
当社のCT GFP-fusion TOPO™ Expression Kitは、緑色蛍光タンパク質(GFP)を、Taqポリメラーゼ増幅遺伝子産物のC末端に融合する、高効率で5分間のクローニング用のpcDNA™3.1⁄CT-GFP-TOPO™ベクターを提供します。pcDNA3.1ベクターは、幅広い哺乳類細胞における一過性または安定したGFP融合タンパク質の高レベルの発現を提供します。蛍光を使用して、生細胞で簡単に発現を検出できます。さらに、これらのベクターから発現した組換えタンパク質は、GFP抗血清を使用してウェスタンブロットで検出できます。
研究用にのみ使用できます。診断用には使用いただけません。
仕様
構成または誘導システム構造的
供給タイプTransfection
使用対象(アプリケーション)レポーターアッセイ
製品タイプTOPO Expression Kit
数量20 reactions
レポーター遺伝子GFP(Cycle 3)
選択剤(真核生物)Geneticin™(G-418)
ベクターTOPO-TAベクター
クローニング法TOPO™-TA
製品ラインTOPO
プロモーターCMV
タンパク質タグGFP(Cycle 3)
Unit SizeEach
組成および保存条件
CT-GFP Fusion Expression kitには2つのボックスが含まれています:1.pcDNA™3.1⁄CT-GFP TOPO™クローニングベクター、dNTP、塩溶液、コントロールPCRテンプレートおよびプライマー、シーケンシングおよびPCRスクリーニング用のフォワードプライマーおよび逆プライマー、およびGFP発現コントロールプラスミドを含むTOPO™クローニングボックス。-20℃で保存2.One Shot™ TOP10ケミカルコンピテント大腸菌、S.O.C.培地、超らせん型コントロールプラスミド。-80℃で保存してください。キットは、適切に保存されている場合、6ケ月間安定していることが保証されます

よくあるご質問(FAQ)

I performed stable selection but my antibiotic-resistant clones do not express my gene of interest. What could have gone wrong?

Here are possible causes and solutions:

Detection method may not be appropriate or sensitive enough:
- We recommend optimizing the detection protocol or finding more sensitive methods. If the protein is being detected by Coomassie/silver staining, we recommend doing a western blot for increased sensitivity. The presence of endogenous proteins in the lysate may obscure the protein of interest in a Coomassie/silver stain. If available, we recommend using a positive control for the western blot.
- Insufficient number of clones screened: Screen at least 20 clones.
- Inappropriate antibiotic concentration used for stable selection: Make sure the antibiotic kill curve was performed correctly. Since the potency of a given antibiotic depends upon cell type, serum, medium, and culture technique, the dose must be determined each time a stable selection is performed. Even the stable cell lines we offer may be more or less sensitive to the dose we recommend if the medium or serum is significantly different.
- Expression of gene product (even low level) may not be compatible with growth of the cell line: Use an inducible expression system.
- Negative clones may result from preferential linearization at a vector site critical for expression of the gene of interest: Linearize the vector at a site that is not critical for expression, such as within the bacterial resistance marker.

I used a mammalian expression vector but do not get any expression of my protein. Can you help me troubleshoot?

Here are possible causes and solutions:

- Try the control expression that is included in the kit
Possible detection problem:

- Detection of expressed protein may not be possible in a transient transfection, since the transfection efficiency may be too low for detection by methods that assess the entire transfected population. We recommend optimizing the transfection efficiency, doing stable selection, or using methods that permit examination of individual cells. You can also increase the level of expression by changing the promoter or cell type.
- Expression within the cell may be too low for the chosen detection method. We recommend optimizing the detection protocol or finding more sensitive methods. If the protein is being detected by Coomassie/silver staining, we recommend doing a western blot for increased sensitivity. The presence of endogenous proteins in the lysate may obscure the protein of interest in a Coomassie/silver stain. If available, we recommend using a positive control for the western blot. Protein might be degraded or truncated: Check on a Northern. Possible time-course issue: Since the expression of a protein over time will depend upon the nature of the protein, we always recommend doing a time course for expression. A pilot time-course assay will help to determine the optimal window for expression. Possible cloning issues: Verify clones by restriction digestion and/or sequencing.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I am using a mammalian expression vector that has the neomycin resistance gene. Can I use neomycin for stable selection in mammalian cells?

No; neomycin is toxic to mammalian cells. We recommend using Geneticin (a.k.a. G418 Sulfate), as it is a less toxic and very effective alternative for selection in mammalian cells.

Is it okay if my construct has an ATG that is upstream of the ATG in my gene of interest? Will it interfere with translation of my gene?

Translation initiation will occur at the first ATG encountered by the ribosome, although in the absence of a Kozak sequence, initiation will be relatively weak. Any insert downstream would express a fusion protein if it is in frame with this initial ATG, but levels of expressed protein are predicted to be low if there is a non-Kozak consensus sequence. If the vector contains a non-Kozak consensus ATG, we recommend that you clone your gene upstream of that ATG and include a Kozak sequence for optimal expression.

Do you offer a GFP-expressing mammalian expression vector that I can use as a control to monitor my transfection and expression?

We offer pJTI R4 Exp CMV EmGFP pA Vector, Cat. No. A14146, which you can use to monitor your transfection and expression.

引用および参考文献 (4)

引用および参考文献
Abstract
Functional analysis of the human papillomavirus type 16 E1=E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization.
Authors:Wang Q, Griffin H, Southern S, Jackson D, Martin A, McIntosh P, Davy C, Masterson PJ, Walker PA, Laskey P, Omary MB, Doorbar J,
Journal:J Virol
PubMed ID:14694114
'High-risk human papillomaviruses, such as human papillomavirus type 16 (HPV16), are the primary cause of cervical cancer. The HPV16 E1=E4 protein associates with keratin intermediate filaments and causes network collapse when expressed in epithelial cells in vitro. Here, we show that keratin association and network reorganization also occur in vivo ... More
Functional domains and DNA-binding sequences of RFLAT-1/KLF13, a Krüppel-like transcription factor of activated T lymphocytes.
Authors:Sakamoto K, Yamaguchi S, Ando R, Miyawaki A, Kabasawa Y, Takagi M, Li CL, Perbal B, Katsube K.
Journal:J Biol Chem
PubMed ID:12050170
'RFLAT-1/KLF13, a member of the Krüppel-like family of transcription factors, was identified as a transcription factor expressed 3-5 days after T lymphocyte activation. It binds to the promoter of the chemokine gene RANTES (regulated on activation normal T cell expressed and secreted) and regulates its ' ... More
Cloning and characterization of AOEB166, a novel mammalian antioxidant enzyme of the peroxiredoxin family.
Authors:Knoops B, Clippe A, Bogard C, Arsalane K, Wattiez R, Hermans C, Duconseille E, Falmagne P, Bernard A
Journal:J Biol Chem
PubMed ID:10521424
Using two-dimensional electrophoresis, we have recently identified in human bronchoalveolar lavage fluid a novel protein, termed B166, with a molecular mass of 17kDa. Here, we report the cloning of human and rat cDNAs encoding B166, which has been renamed AOEB166 for antioxidant enzyme B166. Indeed, the deducedamino acid sequence reveals ... More
Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components.
Authors:Taveau M, Bourg N, Sillon G, Roudaut C, Bartoli M, Richard I,
Journal:Mol Cell Biol
PubMed ID:14645524
Calpain 3 (Capn3) is known as the skeletal muscle-specific member of the calpains, a family of intracellular nonlysosomal cysteine proteases. This enigmatic protease has many unique features among the calpain family and, importantly, mutations in Capn3 have been shown to be responsible for limb girdle muscular dystrophy type 2A. Here ... More